Salvador Espin

Murcia, MU 30003, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin.

Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 30, 2023

Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells.

Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells.

Journal: Frontiers in molecular biosciences
Published: March 09, 2023

Identification of Kukoamine A, Zeaxanthin, and Clexane as New Furin Inhibitors.

Identification of Kukoamine A, Zeaxanthin, and Clexane as New Furin Inhibitors.

Journal: International journal of molecular sciences
Published: January 24, 2022

Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells.

Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells.

Journal: Biomedicines
Published: February 25, 2021

N-Glycosylation as a Tool to Study Antithrombin Secretion, Conformation, and Function.

N-Glycosylation as a Tool to Study Antithrombin Secretion, Conformation, and Function.

Journal: International journal of molecular sciences
Published: October 29, 2020

First exploratory study on the metabolome from plasma exosomes in patients with paroxysmal nocturnal hemoglobinuria.

First exploratory study on the metabolome from plasma exosomes in patients with paroxysmal nocturnal hemoglobinuria.

Journal: Thrombosis research
Published: August 05, 2019

Antithrombin is incorporated into exosomes produced by antithrombin non-expressing cells.

Antithrombin is incorporated into exosomes produced by antithrombin non-expressing cells.

Journal: Biochimie
Published: May 28, 2019

Differential miRNA expression profile and proteome in plasma exosomes from patients with paroxysmal nocturnal hemoglobinuria.

Differential miRNA expression profile and proteome in plasma exosomes from patients with paroxysmal nocturnal hemoglobinuria.

Journal: Scientific reports
Published: July 30, 2018

Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant.

Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant.

Journal: Haematologica
Published: August 02, 2016

Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site.

Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site.

Journal: PloS one
Published: February 02, 2016

Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase.

Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase.

Journal: Scientific reports
Published: October 13, 2015
Showing 1-11 of 11

Last Updated: 09/26/2026